NL

Nigel J. Liverton

Merck: 82 patents #35 of 9,382Top 1%
MS Msd Italia S.R.L.: 4 patents #1 of 58Top 2%
AS Addex Pharma, S.A.: 1 patents #30 of 38Top 80%
📍 Harleysville, PA: #2 of 322 inventorsTop 1%
🗺 Pennsylvania: #233 of 74,527 inventorsTop 1%
Overall (All Time): #21,125 of 4,157,543Top 1%
83
Patents All Time

Issued Patents All Time

Showing 26–50 of 83 patents

Patent #TitleCo-InventorsDate
8461107 HCV NS3 protease inhibitors John A. McCauley, John W. Butcher, Kevin F. Gilbert, Charles J. McIntyre, Michael T. Rudd 2013-06-11
8377873 HCV NS3 protease inhibitors Vincenzo Summa, Joseph P. Vacca, Maria Emilia Di Francesco, Marco Pompei 2013-02-19
8377874 HCV NS3 protease inhibitors Joseph P. Vacca, John A. McCauley, Michael T. Rudd 2013-02-19
8338449 Isoquinolinone potassium channel inhibitors B. Wesley Trotter, Christopher F. Claiborne, Gerald S. Ponticello, Charles J. McIntyre, David A. Claremon 2012-12-25
8309540 HCV NS3 protease inhibitors Joseph P. Vacca, John A. McCauley, Joseph J. Romano, Michael T. Rudd 2012-11-13
8278322 HCV NS3 protease inhibitors M. Katharine Holloway, John A. McCauley, Michael T. Rudd, Joseph P. Vacca, Steven W. Ludmerer +1 more 2012-10-02
8216999 HCV NS3 protease inhibitors M. Katharine Holloway, Steven W. Ludmerer, John A. McCauley, David B. Olsen, Michael T. Rudd +2 more 2012-07-10
8138164 HCV NS3 protease inhibitors Vincenzo Summa, Joseph P. Vacca 2012-03-20
8080654 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors Steven Harper, Vincenzo Summa, John A. McCauley 2011-12-20
7973040 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors Steven Harper, Vincenzo Summa, John A. McCauley 2011-07-05
7879797 HCV NS3 protease inhibitors M. Katharine Holloway, Steven W. Ludmerer, John A. McCauley, David B. Olsen, Michael T. Rudd +1 more 2011-02-01
7763614 Isoquinoline potassium channel inhibitors Richard Isaacs, Christopher J. Dinsmore, B. Wesley Trotter, Douglas C. Beshore, Nathan R. Kett +3 more 2010-07-27
7723352 Isoquinolinone potassium channel inhibitors B. Wesley Trotter, Christopher F. Claiborne, Gerald S. Ponticello, Charles J. McIntyre, David A. Claremon 2010-05-25
7592360 3-fluoro-piperidines as NMDA/NR2B antagonists Christopher F. Claiborne, David A. Claremon, John A. McCauley 2009-09-22
7470664 HCV NS3 protease inhibitors M. Katharine Holloway, Steven W. Ludmerer, John A. McCauley, David B. Olsen, Michael T. Rudd +2 more 2008-12-30
7452893 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists Wayne Thompson, Steven D. Young, Brian Phillips, Peter M. Munson, Willie Whitter +6 more 2008-11-18
7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists John W. Butcher, Charles J. McIntyre, Christopher F. Claiborne, David A. Claremon, John A. McCauley +3 more 2007-08-21
7217716 N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Christopher F. Claiborne, David A. Claremon, Brian Libby, John W. Butcher, John A. McCauley +4 more 2007-05-15
7196095 (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds Tesfaye Biftu, Richard Thomas Beresis, Richard Berger, Steven L. Colletti, James B. Doherty +7 more 2007-03-27
7053089 N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists Christopher F. Claiborne, John W. Butcher, David A. Claremon, Brian Libby, Peter M. Munson +4 more 2006-05-30
6870055 Isoquinolinone potassium channels inhibitors David A. Claremon, Charles J. McIntyre 2005-03-22
6838291 Radioligand and binding assay John W. Butcher, David A. Claremon, Thomas M. Connolly, Jerzy Karczewski, Kenneth Stephen Koblan +3 more 2005-01-04
6767908 Substituted imidazoles having cytokine inhibitory activity Christopher F. Claiborne, David A. Claremon 2004-07-27
6632836 Carbocyclic potassium channel inhibitors Robert K. Baker, Jianming Bao, Jennifer Chee, Maria L. Garcia, Gregory J. Kaczorowski +10 more 2003-10-14
6602872 Substituted pyridazines having cytokine inhibitory activity Charles J. McIntyre, David A. Claremon 2003-08-05